Western Reports Second Quarter Financial Results

TORONTO, ON / ACCESS Newswire / August 26, 2025 / The Western Investment Company of Canada Limited (TSXV:WI) ("Western" or the "Company") today reported its financial and operating results for the three and six months ended June 30, 2025. The interim financial statements and management’s discussion and analysis have been filed on SEDAR+. Unless otherwise […]

Natus Medical Incorporated Files Response to U.S. International Trade Commission’s Investigation

Intends to defend itself against Ceribell's complaint while preserving competition in the industry and improving the quality of patient care Natus Medical Incorporated (“Natus” or the “Company”), the trusted solution source by healthcare providers around the globe to screen, diagnose, and treat disorders affecting the brain and neural pathways, today announced that it has filed

Wetouch Technology Inc. Receives Nasdaq Notification Regarding Delinquent Periodic Reports

CHENGDU, CHINA / ACCESS Newswire / August 26, 2025 / Wetouch Technology Inc. (Nasdaq:WETH) (the "Company"), a manufacturer and supplier of large-format touchscreens, today announced that on August 21, 2025, it received a written notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company is not in compliance

SOC Update: Lawsuit Alleges Sable Offshore Misled Investors on Oil Production – Hagens Berman

SOC Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, CA / ACCESS Newswire / August 26, 2025 / A class-action lawsuit is underway against Sable Offshore Corp. (NYSE:SOC), alleging the company and its executives misrepresented its oil production status to investors. The lawsuit, captioned Johnson v. Sable Offshore Corp., represents those who purchased

Replimune (REPL) Faces Investor Lawsuit Following 77% Stock Crash After FDA Rejects Key Drug – Hagens Berman

REPL Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESS Newswire / August 26, 2025 / Hagens Berman is investigating claims alleged in a new securities class action against Replimune Group, Inc. (NASDAQ:REPL) and its executives after the company’s stock plummeted following the FDA’s rejection of its leading cancer drug, RP1.

AVANTE ANNOUNCES RESULTS FOR THE FIRST FISCAL QUARTER HIGHLIGHTING 25% IMPROVEMENT IN RECURRING MONTHLY REVENUE

AVANTE ANNOUNCES RESULTS FOR THE FIRST FISCAL QUARTER HIGHLIGHTING 25% IMPROVEMENT IN RECURRING MONTHLY REVENUE GlobeNewswire August 26, 2025 Avante Corp. achieved 11% year-over-year revenue growth and 25% improvement in Recurring Monthly Revenue in the fiscal first quarter ended June 30, 2025. The Company achieved Adjusted EBITDA from continuing operations of $0.36 million in the

BIRKS GROUP INC. ANNOUNCES NEW LEADERSHIP

Birks Group Inc. (the “Company” or “Birks Group”) (NYSE American: BGI), today announced that Jean-Christophe Bédos, the Company's President and CEO and Director, is stepping down from his role, effective August 29, 2025. He will continue to support the Company in an advisory capacity during the leadership transition. The decision comes as the Company repositions

Scroll to Top